Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study
Open accessAbstract
Obesity and alcohol interact to increase the risk of death from liver failure in men. In the present study, we aimed to examine whether obesity and alcohol were multiplicative or additive in increasing the risk of hepatocellular carcinoma (HCC) in both men and women. We conducted a prospective, population-based study of 23,712 Taiwanese residents (50.3% men) from 7 townships who underwent an evaluation for liver disease and were followed for 11.6 years for incident HCC. The mean age was 47 (standard deviation, 10) years and the mean body mass index (weight (kg)/height (m)(2)) was 24 (standard deviation, 3). Overall, 305 cases of HCC were identified over 275,126 person-years of follow-up. Age, male sex, alcohol drinking, cigarette smoking, elevated alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus positivity, and diabetes mellitus were each statistically significant predictors of incident HCC in univariate analyses (P < 0.05). Alcohol use and obesity (body mass index ≥30) showed a synergistic association with the risk of incident HCC in both unadjusted analyses (hazard ratio = 7.19, 95% confidence interval: 3.69, 14.00; P < 0.01) and multivariable-adjusted analyses (age, sex, smoking, serum alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus antibody, and diabetes mellitus) (hazard ratio = 3.82, 95% confidence interval: 1.94, 7.52; P < 0.01). Relative excess risks due to interaction, attributable proportion, and synergy index were 4.83, 0.67, and 4.53, respectively, suggesting a multiplicative interaction between alcohol use and obesity. Obesity and alcohol synergistically increase the risk of incident HCC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Alcohol consumption may increase the risk of HCC in persons with obesity, with a synergistic interaction even after adjustment for multiple carcinogenic confounders.
“Alcohol consumption may also increase the risk of HCC in persons with obesity, with a synergistic interaction even after adjustment for multiple carcinogenic confounders.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [96]
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717 · see citing works
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · see citing works
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140 · see citing works
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296 · see citing works
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H., Lu, S., Liaw, Y., You, S., Sun, C., Wang, L., Hsiao, C. K., Chen, P., Chen, D., & Chen, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,220 · see citing works
Hepatocellular carcinoma: Recent trends in the United States
El‐Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 974 · see citing works
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El‐Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 940 · see citing works
ROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 851 · cited 1× · see citing works
“To test whether the interaction is additive or multiplicative, we examined the combined impact of alcohol and obesity on HCC risk by relative excess risk due to interaction (RERI), attributable proportion (AP), and synergy index (SI) and their respective confidence intervals, as previously described (30, 31).”
MethodBurden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
Everhart, J. E., & Ruhl, C. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.038 · Cited by 826 · see citing works
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762 · see citing works
Marrero, J., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.36939 · Cited by 659 · see citing works
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 544 · see citing works
The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx
Rothman, K. J., & Keller, A. Z. (1972) · Journal of Chronic Diseases · doi:10.1016/0021-9681(72)90006-9 · Cited by 518 · see citing works
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
Marrero, J. A., Fontana, R. J., Fu, S., Conjeevaram, H. S., Su, G. L., & Lok, A. S.-F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.005 · Cited by 508 · see citing works
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 494 · see citing works
Bisceglie, A. M. D., RUSTGI, V. K., HOOFNAGLE, J. H., Dusheiko, G. M., & LOTZE, M. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-390 · Cited by 453 · see citing works
Hart, C. L., Morrison, D. S., Batty, G. D., Mitchell, R. J., & Davey Smith, G. (2010) · BMJ · doi:10.1136/bmj.c1240 · Cited by 422 · see citing works
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El‐Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418 · see citing works
Yu, M., Hsu, F.-C., Sheen, I. S., Chu, C., Lin, D., Chen, C., & Liaw, Y. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009060 · Cited by 289 · see citing works
SYNERGY AND ANTAGONISM IN CAUSE-EFFECT RELATIONSHIPS1
ROTHMAN, K. J. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121626 · Cited by 250 · see citing works
Ruhl, C. E., & Everhart, J. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00743-3 · Cited by 242 · see citing works
Estimation of the relative excess risk due to interaction and associated confidence bounds
Richardson, D. B., & Kaufman, J. S. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn411 · Cited by 240 · see citing works
Steatohepatitic Hepatocellular Carcinoma (SH-HCC)
Salomao, M. A., Yu, W. M., Brown, R. S., Emond, J. C., & Lefkowitch, J. H. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f31caa · Cited by 233 · see citing works
Expression of MAGE-antigens in normal tissues and cancer
Jungbluth, A. A., BUSAM, K. J., Kolb, D., Iversen, K., Coplan, K. A., Chen, Y., Spagnoli, G. C., & Old, L. J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4 · Cited by 214 · see citing works
Long-Term Outcomes in Hepatitis B: The REVEAL-HBV Study
Chen, C., Iloeje, U. H., & Yang, H. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.08.005 · Cited by 193 · see citing works
Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: A longitudinal study
Lin, D., Sheen, I., Chiu, C., Lin, S., Kuo, Y., & Liaw, Y. (1993) · Journal of Clinical Ultrasound · doi:10.1002/jcu.1870210502 · Cited by 170 · see citing works
Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy
Franceschi, S., Montella, M., Polesel, J., Vecchia, C. L., Crispo, A., Maso, L. D., Casarin, P., Izzo, F., Tommasi, L. G., Chemin, I., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0702 · Cited by 162 · see citing works
Mechanisms of alcohol‐induced hepatic fibrosis: A summary of the Ron Thurman Symposium†
Purohit, V., & Brenner, D. A. (2006) · Hepatology · doi:10.1002/hep.21107 · Cited by 161 · see citing works
Wang, L., You, S., Lu, S., Ho, H. C., Wu, M. H., Sun, C. A., Yang, H., & Chen, C. (2003) · Cancer Causes & Control · doi:10.1023/a:1023636619477 · Cited by 154 · see citing works
Measuring additive interaction using odds ratios
Kalilani, L., & Atashili, J. (2006) · Epidemiologic Perspectives & Innovations · doi:10.1186/1742-5573-3-5 · Cited by 144 · see citing works
Loomba, R. S., Bettencourt, R., & Barrett-Connor, E. L. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04141.x · Cited by 110 · see citing works
Hepatocellular Carcinoma and Sex
Wands, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmcibr075652 · Cited by 109 · see citing works
Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States
Kim, W. R., Gores, G. J., BENSON, J., Therneau, T. M., & MELTONIII, L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.001 · Cited by 106 · see citing works
Obesity and Alcohol Synergize to Increase the Risk of Incident Hepatocellular Carcinoma in Men
Loomba, R. S., Yang, H., Su, J., Brenner, D. A., Iloeje, U. H., & Chen, C. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.027 · Cited by 92 · see citing works
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
Bugianesi, E., Vanni, E., & Marchesini, G. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0029-z · Cited by 70 · see citing works
Nonalcoholic Fatty Liver Disease: Implications for Alcoholic Liver Disease Pathogenesis
Diehl, A. M. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00004 · Cited by 37 · see citing works
Nonalcoholic Fatty Liver Disease: Implications for Alcoholic Liver Disease Pathogenesis
Diehl, A. M. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02368.x · Cited by 37 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · see citing works
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works
Rychik, J. R., Atz, A. M., Celermajer, D. S., Deal, B. J., Gatzoulis, M. Α., Gewillig, M. H. M. L., Hsia, T., Hsu, D. T., Kovacs, A. H., McCrindle, B. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000696 · Cited by 1,036 · see citing works
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Kerr, J., Anderson, C. A. M., & Lippman, S. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30411-4 · Cited by 677 · see citing works
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652 · see citing works
Jeng, W., Papatheodoridis, G., & Lok, A. S.-F. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01468-4 · Cited by 572 · see citing works
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553 · see citing works
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 510 · see citing works
Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
Altekruse, S. F., Henley, S. J., Cucinelli, J. E., & McGlynn, K. A. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.11 · Cited by 429 · see citing works
Loomba, R. S., Lim, J. K., Patton, H. M., & El‐Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 360 · see citing works
Younossi, Z., & Henry, L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.005 · Cited by 334 · see citing works
“HCC Patients with NAFLD or ALD are at risk for developi ng HCC, which leads to death or liver transplantation [77-86].”
BackgroundNonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327 · see citing works
Chemopreventive strategies in hepatocellular carcinoma
Singh, S., Singh, P. P., Roberts, L. R., & Sánchez, W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.143 · Cited by 272 · see citing works
Åberg, F., Helenius‐Hietala, J., Puukka, P., Färkkilä, M., & Jula, A. (2018) · Hepatology · doi:10.1002/hep.29631 · Cited by 267 · see citing works
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264 · see citing works
Pathogenesis of Alcoholic Liver Disease
Dunn, W., & Shah, V. H. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.02.004 · Cited by 221 · see citing works
Kim, W. R., Loomba, R. S., Berg, T., Schall, R. A., Yee, L. J., Dinh, P. V., Flaherty, J. F., Martins, E. B., Therneau, T. M., Jacobson, I. M., et al. (2015) · Cancer · doi:10.1002/cncr.29537 · Cited by 212 · see citing works
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Dhanasekaran, R., Bandoh, S., & Roberts, L. (2016) · F1000Research · doi:10.12688/f1000research.6946.1 · Cited by 199 · see citing works
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207 · see citing works
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M., Dufour, J., Gerbes, A., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 179 · see citing works
Non-alcoholic fatty liver disease: What the clinician needs to know
Machado, M. V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12956 · Cited by 209 · see citing works
Chan, A. W. H., Wong, G. L., Chan, H., TONG, J. H. M., Yu, Y., Choi, P. C. L., Chan, H. L., To, K., & Wong, V. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13536 · Cited by 200 · see citing works
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., & Yoon, S. K. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0176 · Cited by 177 · see citing works
Diet and liver cancer risk: a narrative review of epidemiological evidence
Yang, W., Zeng, X., Liu, Z., Zhao, Q.-H., Tan, Y., Gao, J., Li, H., & Xiang, Y. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001208 · Cited by 164 · see citing works
Boyle, M., Masson, S., & Anstee, Q. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.006 · Cited by 159 · see citing works
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Degasperi, E., & Colombo, M. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30018-8 · Cited by 155 · see citing works
Desai, B. N., Singhal, G., Watanabe, M., Stevanovic, D., Lundasen, T., Fisher, F. M., Mather, M. L., Vardeh, H. G., Douris, N., Adams, A. C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.004 · Cited by 150 · see citing works
Roh, Y. S., Zhang, B., Loomba, R. S., & Seki, E. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00031.2015 · Cited by 146 · see citing works
Lazebnik, L. B., Голованова, Е. В., Туркина, С. В., Raikhelson, K. L., Okovityy, S. V., Drapkina, O. M., Maev, I. V., Ai, M., Ройтберг, Г. Е., Khlynova, O. V., et al. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-185-1-4-52 · Cited by 155 · see citing works
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M., & Arab, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00448 · Cited by 136 · see citing works
Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
Lange, N. F., Radu, P., & Dufour, J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.025 · Cited by 137 · see citing works
Alcohol and hepatocellular carcinoma
Matsushita, H., & Takaki, A. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000260 · Cited by 110 · see citing works
Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma
Hassan, M. M., Abdel-Wahab, R., Kaseb, A., Shalaby, A., Phan, A. T., El-Serag, H. B., Hawk, E., Morris, J., Singh Raghav, K. P., Lee, J.-S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.044 · Cited by 110 · see citing works
Alcoholic Beverage Consumption and Chronic Diseases
Zhou, Y., Zheng, J., Li, S., Zhou, T., Zhang, P., & Li, H. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13060522 · Cited by 107 · see citing works
Loomba, R. S., Liu, J. B., Yang, H., Lee, M., Lu, S., Wang, L., Iloeje, U. H., You, S., Brenner, D. A., & Chen, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.043 · Cited by 105 · see citing works
The impact of obesity and metabolic syndrome on alcoholic liver disease
Chiang, D. J., & McCullough, A. J. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.006 · Cited by 99 · see citing works
Epidemiology of Virus Infection and Human Cancer
Chen, C., Hsu, W.-L., Yang, H., Lee, M., Chen, H.-C., Chien, Y.-C., & You, S. (2013) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-38965-8_2 · Cited by 100 · see citing works
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 89 · see citing works
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Åberg, F. O., & Färkkilä, M. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1701443 · Cited by 87 · see citing works
Alcohol consumption and liver cancer risk: a meta-analysis
Chuang, S., Lee, Y.-C. A., Wu, G.-J., Straíf, K., & Hashibe, M. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0615-3 · Cited by 79 · see citing works
Chrysavgis, L., Giannakodimos, I., Diamantopoulou, P., & Cholongitas, E. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.310 · Cited by 67 · see citing works
Hepatocellular carcinoma and the risk of occupational exposure
Rapisarda, V., Loreto, C., Malaguarnera, M., Ardiri, A., Proiti, M., Giuseppe, R., Frazzetto, E., Ruggeri, M. I., Malaguarnera, G., Bertino, N., et al. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i13.573 · Cited by 79 · see citing works
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK
Williams, R. L., Aithal, G. P., Alexander, G., Allison, M., Armstrong, I. J., Aspinall, R., Baker, A., Batterham, R. L., Brown, K., Burton, R., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32908-3 · Cited by 78 · see citing works
Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies
Tomic, D., Kemp, W. W., & Roberts, S. K. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001235 · Cited by 76 · see citing works
Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease
Mahli, A., & Hellerbrand, C. (2016) · Digestive Diseases · doi:10.1159/000447279 · Cited by 73 · see citing works
Chang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 73 · see citing works
NAFLD in normal weight individuals
DiStefano, J. K., & Gerhard, G. S. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00814-z · Cited by 72 · see citing works
Li, Q., Liu, W., Feng, Y., Hou, H., Zhang, Z., Yu, Q., Zhou, Y., Luo, Q., Luo, Y., Ouyang, H., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.067 · Cited by 71 · see citing works
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
Ramadori, P., Cubero, F. J., Liedtke, C., Trautwein, C., & Nevzorova, Y. A. (2017) · Cancers · doi:10.3390/cancers9100130 · Cited by 70 · see citing works
Alcoholic and non-alcoholic steatohepatitis
Neuman, M. G., French, S. W., French, B. A., Seitz, H. K., Cohen, L. B., Mueller, S., Osna, N. A., Kharbanda, K. K., Seth, D., Bautista, A. P., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.09.005 · Cited by 70 · see citing works
Combined alcoholic and non-alcoholic steatohepatitis
Wandji, L. C. N., Gnemmi, V., Mathurin, P., & Louvet, A. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100101 · Cited by 70 · see citing works
Huang, Y., Wang, T., Yang, S., Lin, S., Fu, S., Hu, J. ‐., Liu, C., Kao, J., & Chen, D. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13341 · Cited by 69 · see citing works
Controversies in the Diagnosis and Management of NAFLD and NASH.
Rinella, M. E., Loomba, R. S., Caldwell, S. H., Kowdley, K. V., Charlton, M., Tetri, B. A., & Harrison, S. A. (2014) · PubMed Central · Cited by 66 · see citing works
Åberg, F., Färkkilä, M., & Männistö, V. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14271 · Cited by 63 · see citing works
Chen, C., Yang, Y., Lin, M., Lee, C., Tsan, Y., Lai, M., Yang, H., Ho, W., & Chen, P. (2018) · International Journal of Cancer · doi:10.1002/ijc.31544 · Cited by 61 · see citing works
Association between proton pump inhibitors and the risk of hepatocellular carcinoma
Shao, Y. J., Chan, T., Tsai, K. K., & Wu, S. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14835 · Cited by 60 · see citing works
Fu, S., Huang, Y., Wang, T., Hu, J. ‐., Chen, D., & Yang, S. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13191 · Cited by 60 · see citing works
Thiele, M. S., Gluud, L. L., Fialla, A. D., Dahl, E., & Krag, A. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107177 · Cited by 56 · see citing works
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study
Zeng, Q., Xu, G., Zhang, J., Li, W., Zhang, D., Li, Z., Liang, H., Li, C., & Yu, Z. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.025 · Cited by 52 · see citing works
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Thomaides-Brears, H. B., Lepe, R., Banerjee, R., & Duncker, C. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02684-3 · Cited by 50 · see citing works
Alcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 50 · see citing works
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 49 · see citing works
Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease
Patel, V. A., Sanyal, A. J., & Sterling, R. K. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.006 · Cited by 48 · see citing works
Im, P. K., Millwood, I. Y., Kartsonaki, C., Guo, Y., Chen, Y., Turnbull, I. J., Yu, C., Du, H., Pei, P., Lv, J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02079-1 · Cited by 47 · see citing works
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Argenziano, M. E., Kim, M. N., Montori, M., Bucchianico, A. D., Balducci, D., Ahn, S. H., & Svegliati‐Baroni, G. (2024) · Hepatology International · doi:10.1007/s12072-024-10692-4 · Cited by 50 · see citing works
Alcohol Use and Gastrointestinal Cancer Risk
Scherübl, H. (2020) · Visceral Medicine · doi:10.1159/000507232 · Cited by 43 · see citing works
Brazilian Journal of Development
(2021) · doi:10.34117/25258761 · Cited by 46 · see citing works
MAFLD: an optimal framework for understanding liver cancer phenotypes
Crane, H., Gofton, C., Sharma, A., & George, J. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02021-7 · Cited by 45 · see citing works
Sripongpun, P., Kaewdech, A., Udompap, P., & Kim, W. R. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101127 · Cited by 45 · see citing works
Rivera‐Esteban, J., Muñoz, S., Higuera, M., Sena, E., Bermúdez-Ramos, M., Bañares, J., Martínez-Gómez, M., Cusidó, M. S., Jiménez-Masip, A., Francque, S., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.03.028 · Cited by 45 · see citing works
Hagström, H., Hegmar, H., & Moreno, C. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12524 · Cited by 40 · see citing works
Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
Leal-Lassalle, H., Estévez‐Vázquez, O., Cubero, F. J., & Nevzorova, Y. A. (2025) · npj gut and liver. · doi:10.1038/s44355-024-00014-8 · Cited by 41 · see citing works
Hou, K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.475 · Cited by 41 · see citing works
How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
Sookoian, S. C., & Pirola, C. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.002 · Cited by 41 · see citing works
Genetic Factors, Viral Infection, Other Factors and Liver Cancer: An Update on Current Progress
Su, C., Lin, Y., & Cai, L. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.4953 · Cited by 40 · see citing works
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Petroni, M. L., Brodosi, L., Marchignoli, F., Musio, A., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11123048 · Cited by 41 · see citing works
Tang, H., Zhang, J., Yu, Z., Ye, L., Li, K., Ding, F., Feng, X., & Meng, W. (2017) · Technology in Cancer Research & Treatment · doi:10.1177/1533034617735931 · Cited by 39 · see citing works
RetractedPeña, S., Mäkelä, P., Laatikainen, T. K., Härkänen, T., Männistö, S., Heliövaara, M., & Koskinen, S. V. P. (2021) · Addiction · doi:10.1111/add.15395 · Cited by 39 · see citing works
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
Ciaula, A. D., Bonfrate, L., Krawczyk, M. J., Frühbeck, G., & Portincasa, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052636 · Cited by 37 · see citing works
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
Ratziu, V., Ghabril, M., Romero‐Gómez, M., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002483 · Cited by 38 · see citing works
Zhang, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i12.3554 · Cited by 38 · see citing works
Epidemiology of Virus Infection and Human Cancer
Chen, C., You, S., Hsu, W., Yang, H., Lee, M., Chen, H., Chen, Y., Liu, J. B., Hu, H.-H., Lin, Y., et al. (2020) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-57362-1_2 · Cited by 37 · see citing works
Yamamura, S., Kawaguchi, T., Nakano, D., Tomiyasu, Y., Yoshinaga, S., Doi, Y., Takahashi, H., Anzai, K., Eguchi, Y., Torimura, T., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13436 · Cited by 36 · see citing works
Vanini, G. (2015) · SLEEP · doi:10.5665/sleep.5334 · Cited by 36 · see citing works
Dash, S., Aydın, Y., & Wu, T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.015 · Cited by 35 · see citing works
Yun, B., Park, H., Ahn, S. H., Oh, J., Kim, B. K., & Yoon, J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002920 · Cited by 34 · see citing works
Hoki, T., Katsuta, E., Yan, L., Takabe, K., & Ito, F. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.008 · Cited by 34 · see citing works
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Zelber‐Sagi, S., Noureddin, M., & Shibolet, O. (2021) · Cancers · doi:10.3390/cancers14010103 · Cited by 33 · see citing works
Management of fatty liver disease with the metabolic syndrome
Machado, M. V., & Cortez‐Pinto, H. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.903798 · Cited by 31 · see citing works
Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity
Innes, H. A., Crooks, C. J., Aspinall, E., Card, T. R., Hamill, V., Dillon, J. F., Guha, I. N., Hayes, P. C., Hutchinson, S. J., West, J., et al. (2021) · Hepatology · doi:10.1002/hep.32123 · Cited by 31 · see citing works
Han, H., Hu, J., Lau, M. Y., Feng, M., Petrovic, L. M., & Ji, C. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00224 · Cited by 31 · see citing works
Zeng, Q., Yu, Z., Shang, J., Xu, G., Sun, C.-Y., Liu, N., Li, C., Lv, J., Liu, Y., Liang, H., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa208 · Cited by 30 · see citing works
Canivet, C. M., Boursier, J., & Loomba, R. S. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1785196 · Cited by 29 · see citing works
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia
Huang, Y., Joseph, J., de Boer, W. B., Cheng, W., Adams, L. A., MacQuillan, G. C., Garas, G., Raftopoulos, S., & Jeffrey, G. P. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.013 · Cited by 28 · see citing works
Bataller, R. A., Cabezas, J., Aller, R., Cots, M. V., Abad, J., Albillos, A., Altamirano, J., Arias, M., Bañares, R., Caballería, J., et al. (2019) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2019.09.006 · Cited by 28 · see citing works
Eroglu, E. I., Huang, B., Ahmadi, M. N., Johnson, N. A., El-Omar, E. M., & Stamatakis, E. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00923-4 · Cited by 28 · see citing works
Alcohol and its associated liver carcinogenesis
Jacob, R., Prince, D. S., Kench, C., & Liu, K. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16248 · Cited by 28 · see citing works
Obesity and excess weight in early adulthood and high risks of arsenic-related cancer in later life
Steinmaus, C., Castriota, F., Catterina Ferreccio, R., Smith, A. H., Yan Yuan, A., Liaw, J., Acevedo, J., Pérez, L., Meza, R., Calcagno, S., et al. (2015) · Environmental Research · doi:10.1016/j.envres.2015.07.021 · Cited by 28 · see citing works
Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 27 · see citing works
- Authors
- Loomba, R., Yang, H.-I., Su, J., Brenner, D., Barrett-Connor, E., Iloeje, U., & Chen, C.-J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Loomba, Rohit
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-24
- Volume
- 177
- Issue
- 4
- Pages
- 333-342
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- PMC
- PMC3626057
- OpenAlex
- W2116448477
- Cited by
- 221
- References
- 37
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 17 · 2023: 21 · 2022: 18 · 2021: 23 · 2020: 17 · 2019: 20 · 2018: 11 · 2017: 12 · 2016: 17 · 2015: 20 · 2014: 13 · 2013: 9
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Epidemiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P30CA23100-27, P30CA023100)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK090303)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- hepatocellular carcinoma, obesity, alcohol consumption, synergistic interaction, multiplicative interaction, body mass index, liver cancer risk factors, hepatitis B, hepatitis C, diabetes mellitus, smoking, alanine aminotransferase, Taiwanese population
- MeSH terms
- Adult, Alanine Transaminase, Alcohol Drinking, Algorithms, Analysis of Variance, Female, Follow-Up Studies, Hepatitis B Surface Antigens, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Obesity, Prospective Studies, Risk Factors, Smoking, Taiwan, Biomarkers, Tumor, Cohort Studies, Body Mass Index, Incidence, Multivariate Analysis, Confidence Intervals, Odds Ratio, Hepatitis C Antibodies, Hepatitis B, Chronic, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
